Clinical study of duvelisib in combination with venetoclax in patients with cancer.

Trial Profile

Clinical study of duvelisib in combination with venetoclax in patients with cancer.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Duvelisib (Primary) ; Venetoclax (Primary)
  • Indications Haematological malignancies
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Oct 2015 According to Infinity Pharmaceuticals media release, company is planning to initiate this trial by the end of 2015.
    • 16 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top